Published

THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Hepatology
Date: 2024-05-31
Source: OpenAlex
DOI: 10.1016/s0168-8278(24)01739-2
PubMed: Unavailable

Authors

Martina Colognesi Daniela Gabbia Andrea Rinaldi Luciano Cascione Ilaria Zanotto Stefano Comai Katia Sayaf Andrea Mattarei Marco Banzato Gianfranco Pasut Franco Folli Lucia Centofanti Sergio Traversa M. Pappagallo Paolo L. Manfredi Sara De Martin

Watch author

Topics and keywords

psilocybin Pharmacology Other Psilocybin Medicine Pharmacology Hallucinogen Psychedelics and Drug Studies

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD2024-05-31

Related papers

Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22 Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-06-10 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01 Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31 Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30